Citadel Advisors »

Mersana Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.6M 2.8M 2.01
2024-03-31 $16M 3.5M 4.48
2023-12-31 $4.6M 2.0M 2.32
2023-09-30 $2.2M 1.8M 1.27
2023-06-30 $880k 267k 3.29
2023-03-31 $528k 128k 4.11
2022-12-31 $3.7M 630k 5.86
2022-06-30 $1.7M 365k 4.64
2022-03-31 $2.8M 714k 3.99
2021-12-31 $2.2M 354k 6.22
2021-09-30 $1.1M 112k 9.44
2021-06-30 $8.3M 611k 13.57
2021-03-31 $10M 643k 16.17
2020-12-31 $56M 2.1M 26.61
2020-09-30 $8.8M 472k 18.62
2020-06-30 $15M 632k 23.40
2020-03-31 $2.7M 461k 5.83
2019-12-31 $1.3M 220k 5.73
2019-09-30 $147k 93k 1.58
2019-06-30 $326k 81k 4.04
2019-03-31 $246k 47k 5.29
2018-12-31 $201k 49k 4.09
2017-06-30 $179k 13k 13.96